Company Profile
Microba Life Sciences provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.
It operates in two segments, Testing Services and Supplements, and R&D. It also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome MetaPanel, a metagenomic test for pathogen detection.
Its portfolio also includes MetaXplore that provides a range of diagnostics solution under the Co-Biome brand, research testing services, and data-driven therapeutics platform that develops therapies for ulcerative colitis, and inflammatory bowel and autoimmune diseases Microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.